{"id":"W4410818233","doi":"10.1200/jco.2025.43.16_suppl.2002","title":"Final clinical and molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion: NCT00626990.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Adjuvant; Glioma; Oncology; Internal medicine; Phases of clinical research; Glioblastoma; Clinical trial; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002794758,0.0009925143,0.001066107,0.0003060817,0.0003136257,0.0007422535,0.0007523739,0.001259485,0.01080237],"category_scores_gemma":[0.002052955,0.0004379381,0.00111436,0.0004448618,0.0005191489,0.0006169231,0.0003589583,0.001785345,0.001180658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001293331,"about_ca_system_score_gemma":0.001687911,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001523458,"about_ca_topic_score_gemma":0.006140635,"domain_scores_codex":[0.9990295,0.0006639131,0.00003400316,0.00009915252,0.0001001534,0.00007318003],"domain_scores_gemma":[0.9991176,0.0001791057,0.0002235859,0.00009122174,0.0000797853,0.0003087484],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9039001,0.005369371,0.006394488,0.00108895,0.002210616,0.0001759523,0.0001138058,0.001501822,0.01628508,0.001233096,0.02538786,0.03633874],"study_design_scores_gemma":[0.9097718,0.05093536,0.01919039,0.0000657318,0.001053021,0.0001918397,0.00002980636,0.0009696787,0.001990708,0.0005899375,0.01517529,0.00003649622],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8847117,0.006540279,0.003996818,0.005059258,0.001093374,0.02868908,0.04630066,0.0003668449,0.02324193],"genre_scores_gemma":[0.8805183,0.001950547,0.007324298,0.004886194,0.0003561779,0.02112763,0.05612592,0.0001780311,0.02753288],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01080237,"threshold_uncertainty_score":0.03613746,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07698644840400602,"score_gpt":0.4798616361549108,"score_spread":0.4028751877509048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}